Denali Therapeutics
Get Full AccessDescription
- Denali Therapeutics Inc. (Denali) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimers disease, Parkinsons disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors).
-
Headquarters:161 Oyster Point Boulevard , South San Francisco, California, United States
More -
Phone Number: +1 650-866-8548
-
Website: https://www.denalitherapeutics.com/
-
Employees:281
-
Revenue:$250 - 500M
-
Legal Name:Denali Therapeutics
-
Denali Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541712 |
Show More
Frequently Asked Questions regarding Denali Therapeutics
-
Where are Denali Therapeutics's Headquarters?
Denali Therapeutics's Headquarters are in 161 Oyster Point Boulevard ,South San Francisco,California,United States
-
What is Denali Therapeutics's phone number?
Denali Therapeutics's phone number is +1 650-866-8548
-
What is Denali Therapeutics's official website?
Denali Therapeutics's official website is https://www.denalitherapeutics.com/
-
What is Denali Therapeutics's Revenue?
Denali Therapeutics's revenue is $250 - 500M
-
What is Denali Therapeutics's NAICS code?
Denali Therapeutics's NAICS code is 541712
-
How many employees are working in Denali Therapeutics
Denali Therapeutics has 281 employees
-
What is Denali Therapeutics's Industry?
Denali Therapeutics is in the industry of Biotechnology
-
Who is Denali Therapeutics's CEO?
Denali Therapeutics's CEO is Ryan Watts

